Dr Kate Weeks
Dr Weeks leads the Molecular Cardiology Group at the Baker Institute. The Molecular Cardiology Group uses in vivo mouse models, cell culture systems, molecular biology approaches and state-of-the-art omic technologies to characterise novel signalling mechanisms that contribute to cardiac remodelling and heart failure. Our current research focuses on a group of enzymes known as protein phosphatases. Specifically, we are interested in how protein phosphatase regulatory subunits control phosphatase activity and function in the context of cardiac remodelling and heart disease. Our findings will inform the development and translation of new therapies for heart failure.
Dr Weeks was awarded her PhD in Biochemistry and Molecular Biology from the University of Melbourne in 2012. She was subsequently awarded a highly competitive Overseas Research Fellowship from the Heart Foundation to undertake postdoctoral training at King's College London under the mentorship of Prof Metin Avkiran. In 2018, Dr Weeks was awarded an Emerging Leader Fellowship from the Baker Institute and The Shine On Foundation, and established the Molecular Cardiology Group. Dr Weeks’ current research is supported by a Future Leader Fellowship from the Heart Foundation, and project grants from The Shine On Foundation and Diabetes Australia.